2022
DOI: 10.1016/j.surg.2022.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Current indications of ex-situ liver resection: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 55 publications
1
4
0
Order By: Relevance
“…Overall mortality rate at 90-day was 11.6%, and mean overall survival was 55.8%, with both parameters being lower in patients undergoing ex-vivo resections for malignant tumors that those with non-malignant tumors, in alignment with previous reports (34). Importantly, in patients undergoing ex-vivo resections for malignant tumors, there was a significant relationship between the maximum tumor size and postoperative liver failure and 90-day mortality rate (33). Feasibility of the technique has been also reported in smaller series including its use for advanced CCA (35) and sarcoma-like tumors (36) with acceptable immediate liver function.…”
Section: Ex-vivo Liver Resectionssupporting
confidence: 83%
See 3 more Smart Citations
“…Overall mortality rate at 90-day was 11.6%, and mean overall survival was 55.8%, with both parameters being lower in patients undergoing ex-vivo resections for malignant tumors that those with non-malignant tumors, in alignment with previous reports (34). Importantly, in patients undergoing ex-vivo resections for malignant tumors, there was a significant relationship between the maximum tumor size and postoperative liver failure and 90-day mortality rate (33). Feasibility of the technique has been also reported in smaller series including its use for advanced CCA (35) and sarcoma-like tumors (36) with acceptable immediate liver function.…”
Section: Ex-vivo Liver Resectionssupporting
confidence: 83%
“…Therefore, its use is based on a case-by-case strict approach, and include patients with malignant and non-malignant tumors (33). A recent meta-analysis evaluated outcomes after ex-vivo resections in 29 studies with reports of 215 patients (33). As expected, R0 resections rate was 100%.…”
Section: Ex-vivo Liver Resectionsmentioning
confidence: 94%
See 2 more Smart Citations
“…This clearly affects how patients with benign liver tumours are managed. Hepatic resection is typically described in one of the following two contexts: first, as a previously reported benign liver lesion that has grown in size with or without clinical symptoms, and second, as a newly discovered liver lesion with a questionable diagnosis (14) . This is also consistent with a research done on 144 patients at the Mansoura Center, where 32 (22.2%) of the patients experienced postoperative problems.…”
Section: Discussionmentioning
confidence: 99%